XML 42 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Basis of Presentation (Tables)
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Components of Marketable Securities
As of March 31, 2023 and December 31, 2022, marketable securities consisted of the following ($ in thousands):
 March 31, 2023
 CostGross
Unrealized Loss 		Carrying Value
Equity securities:
Investment funds - debt securities$38,523 $(5,174)$33,349 
Common stock, preferred stock, and stock funds77,004 (3,351)73,653 
Total - Marketable securities $115,527 $(8,525)$107,002 

 December 31, 2022
 CostGross
Unrealized Loss		Carrying Value
Equity securities:
Investment funds - debt securities$43,155 $(6,771)$36,384 
Common stock, preferred stock, and stock funds78,481 (2,122)76,359 
Total - Marketable securities $121,636 $(8,893)$112,743 
Changes in Accumulated Other Comprehensive Income, Net by Component
Changes in Accumulated Other Comprehensive Income, Net by Component

Essex Property Trust, Inc.
($ in thousands):
 Change in fair
value and amortization
of swap settlements
Balance at December 31, 2022$46,466 
Other comprehensive loss before reclassification(9,949)
Amounts reclassified from accumulated other comprehensive loss5 
Other comprehensive loss(9,944)
Balance at March 31, 2023$36,522 


Essex Portfolio, L.P.
($ in thousands):
 Change in fair
value and amortization
of swap settlements
Balance at December 31, 2022$52,010 
Other comprehensive loss before reclassification(10,299)
Amounts reclassified from accumulated other comprehensive loss5 
Other comprehensive loss(10,294)
Balance at March 31, 2023$41,716 
Schedule of Changes to the Redemption Value of Noncontrolling Interests
The changes in the redemption value of redeemable noncontrolling interests for the three months ended March 31, 2023 is as follows ($ in thousands):
Balance at December 31, 2022$27,150 
Reclassification due to change in redemption value and other3,058 
Balance at March 31, 2023$30,208 
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 March 31, 2023December 31, 2022March 31, 2022December 31, 2021
Cash and cash equivalents - unrestricted$67,712 $33,295 $98,107 $48,420 
Cash and cash equivalents - restricted9,446 9,386 10,446 10,218 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statement of cash flows$77,158 $42,681 $108,553 $58,638 
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 March 31, 2023December 31, 2022March 31, 2022December 31, 2021
Cash and cash equivalents - unrestricted$67,712 $33,295 $98,107 $48,420 
Cash and cash equivalents - restricted9,446 9,386 10,446 10,218 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statement of cash flows$77,158 $42,681 $108,553 $58,638